Koshinski Asset Management, Inc. Moderna, Inc. Transaction History

Koshinski Asset Management, Inc.

  • $1.13 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023
BUY
$118.38 - $210.04 $140,280 - $248,897
1,185 New
1,185 $0
Q2 2022

Jul 12, 2022
SELL
$117.13 - $176.59 $83,045 - $125,202
-709 Closed
0 $0
Q1 2022

Apr 20, 2022
SELL
$126.46 - $235.05 $99,018 - $184,044
-783 Reduced 52.48%
709 $122 Million
Q4 2021

Jan 14, 2022
SELL
$225.82 - $368.51 $208,657 - $340,503
-924 Reduced 38.25%
1,492 $379 Million
Q3 2021

Oct 12, 2021
BUY
$221.9 - $484.47 $238,764 - $521,289
1,076 Added 80.3%
2,416 $929,000
Q2 2021

Jul 26, 2021
SELL
$129.91 - $234.98 $50,794 - $91,877
-391 Reduced 22.59%
1,340 $315,000
Q1 2021

May 06, 2021
SELL
$109.18 - $185.98 $173,159 - $294,964
-1,586 Reduced 47.81%
1,731 $227,000
Q4 2020

Mar 30, 2021
BUY
$65.74 - $169.86 $50,619 - $130,792
770 Added 30.23%
3,317 $347,000
Q4 2020

Feb 05, 2021
BUY
$65.74 - $169.86 $167,439 - $432,633
2,547 New
2,547 $347,000
Q4 2020

Feb 02, 2021
SELL
$65.74 - $169.86 $258,949 - $669,078
-3,939 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$54.34 - $94.85 $214,045 - $373,614
3,939 New
3,939 $297,000
Q2 2020

Jul 29, 2020
SELL
$29.67 - $80.0 $243,590 - $656,800
-8,210 Closed
0 $0
Q1 2020

Apr 30, 2020
BUY
$17.78 - $31.58 $145,973 - $259,271
8,210 New
8,210 $246,000

Others Institutions Holding MRNA

# of Institutions
953
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email